Connor James, Anderson Steven, Davis Niall F
Department of Urology, Beaumont Hospital, Dublin, Ireland.
Royal College of Surgeons in Ireland, Dublin, Ireland.
Cent European J Urol. 2025;78(2):228-236. doi: 10.5173/ceju.2024.0196. Epub 2025 May 25.
The use of ureteral access sheaths (UASs) is an issue of contention among urologists, with their efficacy unclear in retrograde intrarenal surgery (RIRS). Therefore, we performed a systematic review and meta-analysis to assess RIRS with laser lithotripsy for the treatment of urolithiasis with and without the use of UASs.
A systematic literature search was conducted in July 2023 using MEDLINE, EMBASE and the Cochrane library. The quality of the included studies was assessed using the Newcastle-Ottowa scale and Cochrane collaboration risk of bias tool. The primary outcome measures were stone-free rate (SFR), and post-operative complications. Secondary outcomes were operative time (OT), hospital length of stay (LOS) and ureteral injury rate. Effect sizes were calculated by pooled risk ratios (RRs) and mean differences (MDs) with confidence intervals (CIs).
In total, 16 studies met the inclusion criteria. There were 3,123 participants who had RIRS with a UAS and 1,478 without. Pooled analysis revealed no significant difference between groups in SFR (RR = 1.03, 95% CI: 0.99-1.07), complication rate (RR = 1.31, 95% CI: 1.00-1.73), ureteral injuries (RR = 1.13, 95% CI: 0.77-1.65) or LOS (MD = -0.01, 95% CI: from -0.08 to 0.11). OT was significantly longer in the UAS group (MD = 0.35, 95% CI: 0.01-0.7).
The results of this meta-analysis demonstrate that the use of UASs during RIRS does not improve post-operative outcomes and is associated with a longer OT. While there are still times where the use of UASs may be beneficial, their routine use for patients undergoing RIRS is not currently indicated.
输尿管通路鞘(UAS)的使用在泌尿外科医生中存在争议,其在逆行性肾内手术(RIRS)中的疗效尚不清楚。因此,我们进行了一项系统评价和荟萃分析,以评估在使用和不使用UAS的情况下,采用激光碎石术的RIRS治疗尿路结石的效果。
2023年7月,我们使用MEDLINE、EMBASE和Cochrane图书馆进行了系统的文献检索。使用纽卡斯尔-渥太华量表和Cochrane协作偏倚风险工具对纳入研究的质量进行评估。主要结局指标为结石清除率(SFR)和术后并发症。次要结局为手术时间(OT)、住院时间(LOS)和输尿管损伤率。效应量通过合并风险比(RRs)和平均差(MDs)及置信区间(CIs)计算得出。
共有16项研究符合纳入标准。其中3123名参与者接受了使用UAS的RIRS,1478名未使用。汇总分析显示,两组在SFR(RR = 1.03,95% CI:0.99 - 1.07)、并发症发生率(RR = 1.31,95% CI:1.00 - 1.73)、输尿管损伤(RR = 1.13,95% CI:0.77 - 1.65)或LOS(MD = -0.01,95% CI:-0.08至0.11)方面无显著差异。UAS组的OT明显更长(MD = 0.35,95% CI:0.01 - 0.7)。
这项荟萃分析的结果表明,在RIRS期间使用UAS并不能改善术后结局,且与更长的OT相关。虽然在某些情况下使用UAS可能有益,但目前并不建议对接受RIRS的患者常规使用。